Skip to main content

GNAQ Products

GNAQ, also known as Guanine nucleotide-binding protein G(q) subunit alpha, is a 359 amino acid that is 42 kDa, with subcellular nucleus location, expressed in ovary, prostate, testis and colon tissue; necessary modulator or transducer in various transmembrane signaling systems; controls B-cell selection and survival, needed to prevent B-cell-dependent autoimmunity; and also regulates chemotaxis of BM-derived neutrophils and dendritic cells. Studies on this protein have shown a relationship with the following diseases and disorders: bleeding diathesis due to gnaq deficiency, cellular blue nevus, pertussis, melanoma, acanthocytosis, fainting, polycystic ovary syndrome, trypanosomiasis, gitelman syndrome chorea, thyroid nodule, huntington's disease, thyroiditis, chagas disease, alzheimer's disease, melanoma metastasis, vasculitis, neuronitis, erythroleukemia, and heart failure. GNAQ has also shown an interaction with AGTR1, CXCR5, CRHR1, GALR2, HTR2C, and over 100 other interacting proteins in many different pathways including calcium signaling pathway, vascular smooth muscle contraction, gap junction, long-term potentiation, glutamatergic synapse, GPCR downstream signaling, hemostasis, gastrin-CREB signalling pathway via PKC and MAPK, signaling by GPCR, signal amplification.
Show More

44 results for "GNAQ" in Products

44 results for "GNAQ" in Products

GNAQ Products

GNAQ, also known as Guanine nucleotide-binding protein G(q) subunit alpha, is a 359 amino acid that is 42 kDa, with subcellular nucleus location, expressed in ovary, prostate, testis and colon tissue; necessary modulator or transducer in various transmembrane signaling systems; controls B-cell selection and survival, needed to prevent B-cell-dependent autoimmunity; and also regulates chemotaxis of BM-derived neutrophils and dendritic cells. Studies on this protein have shown a relationship with the following diseases and disorders: bleeding diathesis due to gnaq deficiency, cellular blue nevus, pertussis, melanoma, acanthocytosis, fainting, polycystic ovary syndrome, trypanosomiasis, gitelman syndrome chorea, thyroid nodule, huntington's disease, thyroiditis, chagas disease, alzheimer's disease, melanoma metastasis, vasculitis, neuronitis, erythroleukemia, and heart failure. GNAQ has also shown an interaction with AGTR1, CXCR5, CRHR1, GALR2, HTR2C, and over 100 other interacting proteins in many different pathways including calcium signaling pathway, vascular smooth muscle contraction, gap junction, long-term potentiation, glutamatergic synapse, GPCR downstream signaling, hemostasis, gastrin-CREB signalling pathway via PKC and MAPK, signaling by GPCR, signal amplification.
Show More
Applications: ELISA, ICC/IF, Flow
Reactivity: Human
Applications: ELISA, ICC/IF, Flow
Reactivity: Human
Applications: ELISA, ICC/IF, Flow
Reactivity: Human
Applications: ELISA, ICC/IF, Flow
Reactivity: Human
Applications: ELISA, ICC/IF, Flow
Reactivity: Human
Applications: ELISA, ICC/IF, Flow
Reactivity: Human
Applications: IHC, WB
Reactivity: Human, Mouse, Rat
Applications: IHC, WB, ELISA
Reactivity: Human, Mouse, Rat, Porcine
Applications: WB, ELISA
Reactivity: Human, Mouse, Rat
Applications: IHC, WB
Reactivity: Human, Mouse, Rat

Recombinant Monoclonal Antibody

Applications: WB
Reactivity: Human, Rat
Applications: WB
Reactivity: Human, Mouse, Rat

Recombinant Monoclonal Antibody

Applications: PAGE
Applications: WB
Reactivity: Human
Applications: WB
Reactivity: Human
Applications: WB
Applications: IHC
Reactivity: Human
Applications: ELISA, ICC/IF, Flow
Reactivity: Human
Applications: ELISA, ICC/IF, Flow
Reactivity: Human
Applications: ELISA, ICC/IF, Flow
Reactivity: Human
Applications: ELISA, ICC/IF, Flow
Reactivity: Human
Applications: ELISA, ICC/IF, Flow
Reactivity: Human
Applications: ELISA, ICC/IF, Flow
Reactivity: Human
Applications: ELISA, ICC/IF, Flow
Reactivity: Human
Applications: ELISA, ICC/IF, Flow
Reactivity: Human
Results Per Page
5 10 25 50
/ 2